pyridinolcarbamate has been researched along with Chronic Disease in 6 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of lathyric toxins (BAPN) in low dosage (1 g/kg/day) for a period of 8 weeks caused in the rat simultaneous changes in the skin and aortic connective tissues." | 1.26 | [Chronic lathyrism. Protective effect of pyridinol carbamate on connective tissue lesions in the rat (author's transl)]. ( Bouissou, H; Foulquier, F; Julian, M; Pieraggi, MT; Vila, C, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grigor'ian, VA | 1 |
| Klantsa, NA | 1 |
| Prishliak, VD | 1 |
| Klantsa, PN | 1 |
| Shor, NA | 1 |
| Helunenko, AM | 1 |
| Petrunia, AM | 1 |
| Zelenyĭ, II | 1 |
| Bouissou, H | 2 |
| Pieraggi, MT | 2 |
| Julian, M | 2 |
| Foulquier, F | 1 |
| Vila, C | 1 |
| Fisanovich, TI | 1 |
| Tolstova, LG | 1 |
| Bagliani, A | 1 |
| Borri, P | 1 |
| Parravicini, R | 1 |
6 other studies available for pyridinolcarbamate and Chronic Disease
| Article | Year |
|---|---|
[Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
Topics: Adult; Aged; Carbamates; Cholesterol; Chronic Disease; Coronary Disease; Female; Humans; Hyperlipopr | 1981 |
[Disorders of the blood microcirculation in patients with suppurative-necrotic complications in diabetes mellitus and the approaches to their correction].
Topics: Adult; Aged; Chronic Disease; Combined Modality Therapy; Conjunctiva; Diabetes Mellitus, Type 1; Dia | 1998 |
[Chronic lathyrism. Protective effect of pyridinol carbamate on connective tissue lesions in the rat (author's transl)].
Topics: Aminopropionitrile; Animals; Carbamates; Chronic Disease; Connective Tissue; Fibroblasts; Lathyrism; | 1977 |
[Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Carbamates; Chronic Disease; Drug Evaluation; Endarteritis | 1979 |
[Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Carbamates; Chronic Disease; Clofibrate; Drug Combinations | 1975 |
[Chronic lathyrism: inhibitory effect of pyridinol carbamate on aortic atheroma in the rat (author's transl)].
Topics: Aminopropionitrile; Animals; Aorta; Aortic Diseases; Arteriosclerosis; Chronic Disease; Diet, Athero | 1974 |